Skip to main content
. 2017 May 4;12(5):e0176584. doi: 10.1371/journal.pone.0176584

Fig 1. Prevalence of Abs against MAP, proinsulin and ZnT8 homologous epitopes in LADA patients and HCs.

Fig 1

The histograms represent percentages of subjects with Abs positivity to selected epitopes upon single-antigen analysis; sera were tested in duplicate for their reactivity against plate-coated peptides: MAP3865c133–141 (Msh1); ZnT8186-194 (Z1); MAP3865c125-133 (Msh2); ZnT8178-186 (Z2), MAP1,4αgbp157-173 (M1); PI64-80 (PI1); MAP2404c70-85 (M2); PI46-61 (PI2). (a) Dark bars represent LADA patients; light grey bars correspond to HCs. (b) Abs prevalence among LADA 1 (dark bars) and LADA 2 (light grey bars) patient groups. Relative percentages and standard deviations are reported for each bar.